AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

IMRN · NASDAQ · Biotechnology

Immuron (ADR) (IMRN)

Oral bovine-colostrum products for digestive health and travelers’ diarrhea.

$1.18

Pre-market0.00 (0.00%)

At close$1.18(+10.28%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions7 holders · as of Mar 31, 2026	1.32%	84.9K ADS
Insiders5 holders · as of May 14, 2026	2.42%	156.3K ADS
Otherremainder	96.26%	6.20M ADS

6.45M ADS (1 ADS = 40 ordinary shares) as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count is from the company's Jun 2025 annual report; nothing newer is on file here.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Steven George LydeamoreInsiderofficer: Chief Executive Officer	1.22%	3.16M ordinary	Form 4filed Apr 29, 2026 ↗
Morgan StanleyInstitution	0.47%	30,574 ADS	13Fas of Mar 31, 2026
Flavio PalumboInsiderofficer: Chief Commercial Officer	0.44%	1.14M ordinary	Form 4filed May 14, 2026 ↗
Ravi SavarirayanInsiderdirector	0.34%	877,840 ordinary	Form 4filed Apr 29, 2026 ↗
Daniel Jude PollockInsiderdirector	0.29%	743,230 ordinary	Form 4filed May 14, 2026 ↗
XTX Topco LtdInstitution	0.27%	17,383 ADS	13Fas of Mar 31, 2026
Citadel Advisors LLCInstitution	0.21%	13,804 ADS	13Fas of Mar 31, 2026
Two Sigma Securities, LLCInstitution	0.17%	10,906 ADS	13Fas of Mar 31, 2026
Jerry KanellosInsiderofficer: Chief Scientific Officer	0.13%	333,000 ordinary	Form 4filed Apr 29, 2026 ↗
Rhumbline AdvisersInstitution	0.11%	7,367 ADS	13Fas of Mar 31, 2026
BNP Paribas Arbitrage, SNCInstitution	0.07%	4,600 ADS	13Fas of Mar 31, 2026
BlackRock, Inc.Institution	0.00%	225 ADS	13Fas of Mar 31, 2026
Courage Investments Inc.Strategic	—7.40% of class, as filed	—	13Gfiled Jun 22, 2017 ↗
Empery Asset Management, LPInstitution	—4.99% of class, as filed	—	13G/Afiled Jan 15, 2020 ↗

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

7 holders · 84.9K shares · 2 new positions · 4 increased · 3 reduced · 4 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Morgan Stanley	30.6K	0.47%	−26.8K	May 15, 2026
XTX Topco Ltd	17.4K	0.27%	+3.3K	May 15, 2026
Citadel Advisors LLC	13.8K	0.21%	−32.0K	May 15, 2026
Two Sigma Securities, LLC	10.9K	0.17%	+10.9Knew	May 15, 2026
Rhumbline Advisers	7.4K	0.11%	+2.9K	May 12, 2026
BNP Paribas Arbitrage, SNC	4.6K	0.07%	−100	May 12, 2026
BlackRock, Inc.	225	0.00%	+225new	May 13, 2026

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.